Description
Market Synopsis
Global Lactose Intolerance Treatment Market is expected to register a CAGR of 6.29% during the assessment period of 2020 to 2027 to reach USD 42,783.32 Million by 2027. Lactose intolerance is an illness in which patient can not digest sugar in milk that causes diarrhoea, gas and bloating after eating or drinking dairy products.
The global lactose intolerance treatment market is expected to witness a healthy market growth during the review period. The lactose intolerance illness is of four main types of as primary lactase deficiency, secondary lactase deficiency, congenital lactase deficiency, and developmental lactase deficiency. According to the journal of health, population, and Nutrition published in 2017, the lactose intolerance incidences was higher in IBS-D patients as compared to healthy people.
Market Segmentation
Global Lactose Intolerance Treatment Market has been classified into Type, Treatment, Form, and End User.
Based on the type segment, Global Lactose Intolerance Treatment Market has been categorized into primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance. Primary lactose intolerance dominated the market in 2019. Primary lactose intolerance has a high prevalence rate as compared to others.
In terms of treatment the global market has been classified into food supplements, enzyme lactase supplements, probiotics. The food supplements segment is expected to dominate the market due to the largest market share in 2019. The growing adoption of Lactose-free products is fuelling the market growth of this segment.
By form segment, the market has been divided into powder, liquid, tablet. The powder segment held the largest market in 2019. Based on end user segment the global lactose intolerance treatment market has been categorized into homecare, hospitals and clinics, and others. The homecare segment is expected to lead the market during the forecast period owing to the largest share with a CAGR of 6.04% in 2019.
Regional Analysis
Geographically, the Global Lactose Intolerance Treatment Market has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas is likely to command the market during the study period owing to the largest market share in 2019. The region has further been categorized into North America and Latin America with North America is further divided into the US and Canada. The regional market growth is driven by the increasing prevalence of lactose intolerance and product innovation.
The Europe is expected to register second largest market of global lactose intolerance followed by Asia Pacific. The regional market is attributed to the existence of favourable government initiatives, research and development activities, and business expansions by major players.
The lactose intolerance treatment market in Asia-Pacific is anticipated to register the highest market growth expansion during the study period owing to rising healthcare expenditure, distribution of chilled dairy products in China, India, and Australia, and increasing population suffering from lactose intolerance.
Major Players
The Key Players in the Global Lactose Intolerance Treatment Market are Abbott (US)., Nestlé (Switzerland), Cargill, Incorporated (US), Dean Foods (US), and Johnson & Johnson Services, Inc. (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
The Lactose free butter market By form (Powder, Liquid,semi-liquid); By applications (Household, Commercial); By Distributional channel (convenience stores, hypermarket/supermarket, e-retailers, specialty stores); and Region Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030
Table of Contents
TABLE OF CONTENT
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 INTRODUCTION 14
2.2 ASSUMPTIONS & LIMITATIONS 14
2.2.1 ASSUMPTIONS 14
2.2.2 LIMITATIONS 14
2.3 MARKET STRUCTURE 14
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 15
3.2 DATA MINING 15
3.3 SECONDARY RESEARCH 16
3.4 PRIMARY RESEARCH 17
3.5 FORECASTING TECHNIQUES 19
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20
3.6.1 BOTTOM-UP APPROACH 21
3.6.2 TOP-DOWN APPROACH 21
3.6.3 DATA TRIANGULATION 22
3.6.4 VALIDATION 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVERS 23
4.2.1 RISING CASES OF GASTROINTESTINAL DISORDERS 23
4.2.2 INCREASING AWARENESS ABOUT LACTOSE INTOLERANCE AND RELATED COMPLICATIONS 24
4.2.3 INCREASED PREVALENCE OF LACTOSE INTOLERANCE 24
4.3 RESTRAINTS 25
4.3.1 SIDE-EFFECTS ASSOCIATED WITH SUPPLEMENTS 25
4.4 OPPORTUNITIES 25
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS 26
5.1.1 R&D 26
5.1.2 MANUFACTURING 26
5.1.3 DISTRIBUTION & SALES 26
5.1.4 POST-SALES MONITORING 26
5.2 PORTER’S FIVE FORCES MODEL 27
5.2.1 THREAT OF NEW ENTRANTS 27
5.2.2 BARGAINING POWER OF SUPPLIERS 27
5.2.3 THREAT OF SUBSTITUTES 28
5.2.4 BARGAINING POWER OF BUYERS 28
5.2.5 INTENSE RIVALRY 28
5.3 INVESTMENT OPPORTUNITIES 28
6 LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
6.1 INTRODUCTION 29
6.2 PRIMARY LACTOSE INTOLERANCE 31
6.3 SECONDARY LACTOSE INTOLERANCE 31
6.4 CONGENITAL/DEVELOPMENTAL LACTOSE INTOLERANCE 32
7 LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
7.1 INTRODUCTION 33
7.2 FOOD SUPPLEMENTS 35
7.3 ENZYME LACTASE SUPPLEMENTS 35
7.4 PROBIOTICS 36
8 LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
8.1 INTRODUCTION 37
8.2 POWDER 39
8.3 LIQUID 39
8.4 TABLETS & CAPSULES 40
9 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET BY, END USER
9.1 INTRODUCTION 41
9.2 HOMECARE 43
9.3 HOSPITALS & CLINICS 43
10 GLOBAL LACTOSE INTOLERANCE TREATMENT MARKET, BY REGION
10.1 INTRODUCTION 44
10.2 AMERICAS 46
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1 NORTH AMERICA 49
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1.1 US 51
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.1.2 CANADA 53
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.2.2 LATIN AMERICA 55
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3 EUROPE 58
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1 WESTERN EUROPE 61
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.1 GERMANY 64
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.2 FRANCE 66
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.3 UK 68
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.4 ITALY 70
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.5 SPAIN 72
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.1.6 REST OF WESTERN EUROPE 74
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.3.2 EASTERN EUROPE 76
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4 ASIA-PACIFIC 78
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.1 CHINA 81
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.2 AUSTRALIA 83
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.3 JAPAN 85
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.4 INDIA 87
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.5 SOUTH KOREA 89
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.4.6 REST OF THE ASIA-PACIFIC 91
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5 MIDDLE EAST & AFRICA 93
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5.1 MIDDLE EAST 96
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
10.5.2 AFRICA 98
LACTOSE INTOLERANCE TREATMENT MARKET, BY TYPE
LACTOSE INTOLERANCE TREATMENT MARKET, BY TREATMENT
LACTOSE INTOLERANCE TREATMENT MARKET, BY FORM
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 100
11.2 COMPANY SHARE ANALYSIS 100
12 COMPANY PROFILES
12.1 JOHNSON & JOHNSON SERVICES, INC. 101
12.1.1 COMPANY OVERVIEW 101
12.1.2 FINANCIAL OVERVIEW 101
12.1.3 PRODUCTS/SERVICES OFFERED 102
12.1.4 KEY DEVELOPMENTS 102
12.1.5 SWOT ANALYSIS 102
12.1.6 KEY STRATEGIES 102
12.2 NESTLÉ 103
12.2.1 COMPANY OVERVIEW 103
12.2.2 FINANCIAL OVERVIEW 103
12.2.3 PRODUCTS/SERVICES OFFERED 104
12.2.4 KEY DEVELOPMENTS 104
12.2.5 SWOT ANALYSIS 104
12.2.6 KEY STRATEGIES 105
12.3 ABBOTT 106
12.3.1 COMPANY OVERVIEW 106
12.3.2 FINANCIAL OVERVIEW 106
12.3.3 PRODUCTS/SERVICES OFFERED 106
12.3.4 KEY DEVELOPMENTS 107
12.3.5 SWOT ANALYSIS 107
12.3.6 KEY STRATEGIES 107
12.4 DEERLAND ENZYMES, INC. 108
12.4.1 COMPANY OVERVIEW 108
12.4.2 FINANCIAL OVERVIEW 108
12.4.3 PRODUCTS/SERVICES OFFERED 108
12.4.4 KEY DEVELOPMENTS 108
12.4.5 SWOT ANALYSIS 109
12.4.6 KEY STRATEGIES 109
12.5 RITTER PHARMACEUTICALS 110
12.5.1 COMPANY OVERVIEW 110
12.5.2 FINANCIAL OVERVIEW 110
12.5.3 PRODUCTS/SERVICES OFFERED 110
12.5.4 KEY DEVELOPMENTS 110
12.5.5 SWOT ANALYSIS 111
12.5.6 KEY STRATEGIES 111
12.6 GUARDIAN DRUG COMPANY 112
12.6.1 COMPANY OVERVIEW 112
12.6.2 FINANCIAL OVERVIEW 112
12.6.3 PRODUCTS/SERVICES OFFERED 112
12.6.4 KEY DEVELOPMENTS 112
12.6.5 SWOT ANALYSIS 113
12.6.6 KEY STRATEGIES 113
12.7 NOVOZYMES 114
12.7.1 COMPANY OVERVIEW 114
12.7.2 FINANCIAL OVERVIEW 114
12.7.3 PRODUCTS/SERVICES OFFERED 114
12.7.4 KEY DEVELOPMENTS 115
12.7.5 SWOT ANALYSIS 115
12.7.6 KEY STRATEGIES 115
12.8 CARGILL, INCORPORATED 116
12.8.1 COMPANY OVERVIEW 116
12.8.2 FINANCIAL OVERVIEW 116
12.8.3 PRODUCTS/SERVICES OFFERED 116
12.8.4 KEY DEVELOPMENTS 116
12.8.5 SWOT ANALYSIS 117
12.8.6 KEY STRATEGIES 117
12.9 ARLA FOODS 118
12.9.1 COMPANY OVERVIEW 118
12.9.2 FINANCIAL OVERVIEW 118
12.9.3 PRODUCTS/SERVICES OFFERED 119
12.9.4 KEY DEVELOPMENTS 119
12.9.5 SWOT ANALYSIS 119
12.9.6 KEY STRATEGIES 120
12.10 DEAN FOODS 121
12.10.1 COMPANY OVERVIEW 121
12.10.2 FINANCIAL OVERVIEW 121
12.10.3 PRODUCTS/SERVICES OFFERED 121
12.10.4 KEY DEVELOPMENTS 122
12.10.5 SWOT ANALYSIS 122
12.10.6 KEY STRATEGIES 122
13 APPENDIX
13.1 REFERENCES 123
13.2 RELATED REPORTS 123
